Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -2.27% is 76% below its 5-year average of -1.29%, near the high end of its 5-year range (-88.57%–16.88%).
As of the fiscal period ended Tuesday, March 31, 2026. 86.64% above its 12-month average of -16.96%.
Reported quarterly operating margin; no daily interpolation.
OPERATING MARGIN
-2.27%
OPERATING MARGIN AVG TTM
-16.96%
OPERATING MARGIN AVG 3Y
1.97%
OPERATING MARGIN AVG 5Y
3.07%
OPERATING MARGIN AVG 10Y
5.53%
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+86.64%
CURRENT VS 3Y AVG
-214.78%
CURRENT VS 5Y AVG
-173.72%
CURRENT VS 10Y AVG
-141.01%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
15.12%
median of 79 covered companies
CURRENT VS SECTOR MEDIAN
-114.99%
vs the sector median at left
Market Cap
$22.03B
Operating Margin
45.34%
TTM Avg
47.77%
3Y Avg
49.26%
5Y Avg
45.01%
Market Cap
$18.99B
Operating Margin
15.61%
TTM Avg
16.64%
3Y Avg
15.15%
5Y Avg
12.43%
Market Cap
$22.32B
Operating Margin
-158.13%
TTM Avg
-140.72%
3Y Avg
-73.36%
5Y Avg
-52.24%
Market Cap
$16.97B
Operating Margin
17.49%
TTM Avg
19.66%
3Y Avg
22.41%
5Y Avg
27.16%
Market Cap
$24.28B
Operating Margin
31.57%
TTM Avg
14.26%
3Y Avg
15.92%
5Y Avg
12.23%
Market Cap
$16.41B
Operating Margin
20.97%
TTM Avg
21.16%
3Y Avg
19.82%
5Y Avg
19.12%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Viatris Inc. (VTRS) | $20.55B | -2.27% | -16.96% | 1.97% | 3.07% |
| United Therapeutics Corporation (UTHR)vs › | $22.03B | 45.34% | 47.77% | 49.26% | 45.01% |
| Zimmer Biomet Holdings, Inc. (ZBH)vs › | $18.99B | 15.61% | 16.64% | 15.15% | 12.43% |
| Moderna, Inc. (MRNA)vs › | $22.32B | -158.13% | -140.72% | -73.36% | -52.24% |
| STERIS plc (STE)vs › | $22.68B | 18.56% | 17.21% | 17.04% | 16.18% |
| BioNTech SE (BNTX)vs › | $23.16B | -22.63% | -35.20% | 5.18% | 14.03% |
| Hologic, Inc. (HOLX)vs › | $16.97B | 17.49% | 19.66% | 22.41% | 27.16% |
| Incyte Corporation (INCY)vs › | $24.28B | 31.57% | 14.26% | 15.92% | 12.23% |
| Medpace Holdings, Inc. (MEDP)vs › | $16.41B | 20.97% | 21.16% | 19.82% | 19.12% |
| West Pharmaceutical Services, Inc. (WST)vs › | $24.72B | 20.64% | 20.32% | 22.80% | 22.92% |
Gross Margin
34.4%
Operating Margin
-2.3%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-03-31 | -2.27% |
| 2025-12-31 | -7.17% |
| 2025-09-30 | 6.69% |
| 2025-06-30 | 6.50% |
| 2025-03-31 | -88.57% |
| 2024-12-31 | -5.10% |
| 2024-09-30 | 6.02% |
| 2024-06-30 | -6.32% |
| 2024-03-31 | 5.57% |
| 2023-12-31 | -11.84% |
| 2023-09-30 | 11.46% |
| 2023-06-30 | 9.42% |
| 2023-03-31 | 10.72% |
| 2022-12-31 | -5.19% |
| 2022-09-30 | 13.73% |
| 2022-06-30 | 13.33% |
| 2022-03-31 | 16.88% |
| 2021-12-31 | -1.79% |
| 2021-09-30 | 7.88% |
| 2021-06-30 | -1.04% |
| 2021-03-31 | -6.01% |
| 2020-12-31 | -24.32% |
| 2020-09-27 | 11.82% |
| 2020-06-28 | 4.91% |
| 2020-03-29 | 7.05% |
| 2019-12-31 | 8.53% |
| 2019-09-29 | 10.93% |
| 2019-06-29 | 3.35% |
| 2019-03-30 | 0.96% |
| 2018-12-30 | 7.56% |
| 2018-09-29 | 11.82% |
| 2018-06-29 | 6.37% |
| 2018-03-30 | 5.80% |
| 2017-12-30 | 12.98% |
| 2017-09-29 | 10.60% |
| 2017-06-29 | 15.99% |
| 2017-03-30 | 8.37% |
| 2016-12-30 | 9.66% |
| 2016-09-29 | -4.28% |
| 2016-06-29 | 16.05% |
| 2016-03-30 | 4.82% |
| 2015-12-30 | 17.02% |
| 2015-09-29 | 22.30% |
| 2015-06-29 | 11.66% |
| 2015-03-30 | 8.51% |
| 2014-12-30 | 18.85% |
| 2014-09-29 | 23.75% |
| 2014-06-29 | 12.31% |
| 2014-03-30 | 13.93% |
| 2013-12-30 | 15.11% |
| 2013-09-29 | 19.23% |
